[
Agarwal A., K.P. Singh and A. Jain. 2010. Medical significance and management of staphylococcal biofilm. FEMS Immunol. Med. Microbiol. 58: 147–160.10.1111/j.1574-695X.2009.00601.x19793317
]Search in Google Scholar
[
Anderson V.E, T.D. Gootz and N. Osheroff. 1998. Topoisomerase IV catalysis and the mechanism of quinolone action. J. Biol. Chem. 273: 17879–17885.10.1074/jbc.273.28.178799651393
]Search in Google Scholar
[
Arciola C.R., D. Campoccia, S. Gamberini, M.E. Donati, V. Pirini, L. Visai, P. Speziale and L. Montanaro. 2005. Antibiotic resistance in expolysaccharide-forming Staphylococcus epidermidis clinical isolated from orthopedic implant infections. Biomaterial 26: 6530–6535.10.1016/j.biomaterials.2005.04.03115949842
]Search in Google Scholar
[
Basarab G.S., J. Manchester, S. Bist, P.A. Boriack-Sjodin, B. Dan- gel, R. Illingworth, B.A. Sherer, S. Sriram, M. Uria-Nickelsen and A.E. Eakin. 2013. Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents. J. Med. Chem. 56: 8712–8735.10.1021/jm401208b24098982]Search in Google Scholar
[
Bielenica A., J. Stefańska, K. Stępień, A. Napiórkowska, E. Augu- stynowicz-Kopeć, G. Sanna, S. Madeddu, S. Boi, G. Giliberti, M. Wrzosek and othres. 2015. Synthesis, cytotoxicity, antimicrobial activity of thiourea derivatives incorporatinf 3-(trifluoromethyl) phenyl moiety. Eur. J. Med. Chem. 101: 111–125.
]Search in Google Scholar
[
Bridier A., R. Brandet, V. Thomas and F. Dubois-Brissonnet. 2011. Resistance of bacterial biofilms to desinfectants: a review. Biofouling 27: 1017–1032.10.1080/08927014.2011.62689922011093
]Search in Google Scholar
[
Chambers H.F. and F.R. DeLeo. 2009. Waves of resistance: Staphylococcus aureus in the antibiotic area. Nat. Rev. Microbiol. 7: 629–641.10.1038/nrmicro2200287128119680247]Search in Google Scholar
[
Chikhalia K.H. and M.J. Patel. 2009. Design, synthesis and evaluation of some 1,3,5-triazinyl urea and thiourea derivatives as antimicrobial agents. J. Enz. Inhib. Med. Chem. 24: 960–966.
]Search in Google Scholar
[
Clinical and Laboratory Standards Institute (CLSI). 1999. Methods for determining bactericidal activity of antimicrobial agents – approved guideline M26-A. Wayne, Pennsylvania, USA.
]Search in Google Scholar
[
Clinical and Laboratory Standards Institute (CLSI). 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically – approved Standard M7-A9. Pennsylvania, USA.
]Search in Google Scholar
[
Costerton J.W., P.S. Stewart and E.P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284: 1318–1322.10.1126/science.284.5418.131810334980
]Search in Google Scholar
[
Cunha S., F.C. Macedo Jr., G.A.N Costa, M.T. Rodrigues Jr., R.B.V. Verde, L.C de Souza Neta, I. Vencato, C. Lariucci and F.P. Sá. 2007. Antimicrobial activity and structural study of disubstituted thiourea derivatives. Monatsh. Chem. 138: 511–516.10.1007/s00706-007-0600-y
]Search in Google Scholar
[
Donlan R.M. 2001. Biofilms and device – associated infections. Emerg. Infect. Disc. 7: 277–281.10.3201/eid0702.010226263170111294723
]Search in Google Scholar
[
Donlan R.M. and J.W. Costerton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15: 167–193.10.1128/CMR.15.2.167-193.200211806811932229
]Search in Google Scholar
[
Ehmann D.M. and S.D. Lahiri. 2014. Novel compounds targeting bacterial DNA topoisomerase/DNA gyrase. Curr. Opin. Pharmacol. 18: 76–83.10.1016/j.coph.2014.09.00725271174
]Search in Google Scholar
[
Faidallah H.M., S.A. Rostom, S.A. Basaif, M.S. Makki and K.A. Khan. 2013. Synthesis and biological evaluation of some novel urea and thiourea derivatives of isoxazolo[4,5-d]pyridazine and structurally related thiazolo[4,5-d]pyridazine as antimicrobial agents. Arch. Pharm. Res. 36: 1354–1368.
]Search in Google Scholar
[
Fournier B., X. Zhao, T. Lu, K. Drlica and D.C. Hooper. 2000. Selective Targeting of Topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis. Antimicrob. Agents Chemother. 44: 2160–2165.10.1128/AAC.44.8.2160-2165.20009002910898691]Search in Google Scholar
[
Heczko P.B., M. Wróblewska and A. Pietrzyk (eds). 2014. Microbiology (in Polish). Wydawnictwo Lekarskie PZWL, Warszawa.
]Search in Google Scholar
[
Høiby N., T. Bjarnsholt, M. Givscov, S. Molin and O. Ciofu. 2010. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents 35: 322–332.10.1016/j.ijantimicag.2009.12.01120149602
]Search in Google Scholar
[
Kada T., K. Hirano and Y. Shirasu. 1980. Bacillus subtilis recassay test. In: Seeres F.J. and A. Hollaender (eds). Chemical Mutagens 6: 149–173.10.1007/978-1-4613-3072-1_6
]Search in Google Scholar
[
Keche A.P., G.D. Hatnapure, R.H. Tale, A.H. Rodge and V.M. Kamble. 2012. Synthesis, anti-inflammatory and antimicrobial evaluation of novel 1-acetyl-3,5-diaryl-4,5-dihydro (1H) pyrazole derivatives bearing urea, thiourea and sulfonamide moieties. Bioorg. Med. Chem. Lett. 22: 6611–6615.10.1016/j.bmcl.2012.08.11823026000
]Search in Google Scholar
[
Leclercq R. 2009. Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci. Clin. Microbiol. Infect. 15: 224–231.10.1111/j.1469-0691.2009.02739.x19335370
]Search in Google Scholar
[
Mack D., H. Rohde, L.G. Harris, A.P. Davies, M.A. Horstkotte and J.K. Knobloch. 2006. Biofilm formation in medical device-related infection. Int. J. Artif. Organs 29: 343–359.10.1177/03913988060290040416705603
]Search in Google Scholar
[
Maki D.G., D.M. Kluger and C.J. Crinch. 2006. The risk of bloodstream infection in adults with different intravascular devices. A systematic review of 200 published prospective studies. Mayo Clin. Proc. 81: 1159–1171.10.4065/81.9.115916970212
]Search in Google Scholar
[
Meng C., Y. Qingsong and S. Hongmin. 2013. Novel strategies for the prevention and treatment of biofilm related infections. Int. J. Mol. Sci. 14: 18488–18501.10.3390/ijms140918488379479124018891
]Search in Google Scholar
[
Mishra A. and S. Batra. 2013. Thiourea and guanidine derivatives as antimalarial and antimicrobial agents. Curr. Top. Med. Chem. 13: 2011–2025.10.2174/1568026611313999012623895095
]Search in Google Scholar
[
Otto M. 2008. Staphylococcal biofilms. Curr. Top Microbiol. Immunol. 322: 207–228.10.1007/978-3-540-75418-3_10277753818453278
]Search in Google Scholar
[
Otto M. 2009. Staphylococcus epidermidis – The “accidental” pathogen. Nat. Rev. Microbiol. 7: 555–557.10.1038/nrmicro2182280762519609257
]Search in Google Scholar
[
Ranise A., A. Spallarossa, S. Schenone, O. Bruno, F. Bondavalli, L. Vargiu, T. Marceddu, M. Mura, P. La Colla and A. Pani. 2003. Design, synthesis, SAR, and molecular modeling studies of acylthiocarbamates: a novel series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors structurally related to phenethylthiazolylthiourea derivatives. J. Med. Chem. 46: 768–781.
]Search in Google Scholar
[
Sadaie Y. and T. Kada. 1976. Recombination-deficient mutants of Bacillus subtilis. J. Bacteriol. 125: 489–500.10.1128/jb.125.2.489-500.1976236107812867
]Search in Google Scholar
[
Saeed A., U. Shaheen, A. Hameed and S.H.Z. Naqvi. 2009. Synthesis, characterization and antimicrobial activity of some new 1-(fluoro- benzoyl)-3-(fluorophenyl)thioureas. J. Fluor. Chem. 130: 1028–1034.
]Search in Google Scholar
[
Saeed S., N. Rashid, P.G. Jones, M. Ali and R. Hussain. 2010. Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents. Eur. J. Med. Chem. 45: 1323–1331.
]Search in Google Scholar
[
Siwek A., P. Stączek and J. Stefańska. 2011. Synthesis and structureactivity relationship studies of 4-arylthiosemicarbazides as topoisomerase IV inhibitors with Gram-positive antibacterial activity. Search for molecular basis of antibacterial activity of thiosemicarbazides. Eur. J. Med. Chem. 46: 5717–5726.10.1016/j.ejmech.2011.09.03421978836
]Search in Google Scholar
[
Stefańska J., G. Nowicka, Struga M, D. Szulczyk, A.E. Kozioł, E. Augustynowicz-Kopeć, A. Napiórkowska, A. Bielenica, W. Filipowski and others. 2015. Antimicrobial and anti-biofilm activity of thiourea derivatives incorporating a 2-aminothiazole scaffold. Chem. Pharm. Bull. 63: 1–12.10.1248/cpb.c14-0083725757494
]Search in Google Scholar
[
Struga M., S. Rosołowski, J. Kossakowski and J. Stefańska. 2010. Synthesis and microbiological activity of thiourea derivatives of 4-azatricyclo[5.2.2.0(2,6)]undec-8-ene-3,5-dione. Arch. Pharm. Res. 33: 47–54.
]Search in Google Scholar
[
Suresha G.P., R. Suhas, W. Kapfo and D.C. Gowda. 2011. Urea/ thiourea derivatives of quinazolinone-lysine conjugates: synthesis and structure-activity relationships of a new series of antimicrobials. Eur. J. Med. Chem. 46: 2530–2540.10.1016/j.ejmech.2011.03.04121481990
]Search in Google Scholar
[
Vega-Pérez J.M., I. Periñán, M. Argandoña, M. Vega-Holm, C. Palo-Nieto, E. Burgos-Morón, M. López-Lázaro, C. Vargas, J.J. Nieto and F. Iglesias-Guerra. 2012. Isoprenyl-thiourea and urea derivatives as new farnesyl diphosphate analogues: synthesis and in vitro antimicrobial and cytotoxic activities. Eur. J. Med. Chem. 58: 591–612.10.1016/j.ejmech.2012.10.04223174318]Search in Google Scholar